Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Michael Powell

Affiliations

  • Director at Synlogic Inc. (SYBX), 2019-06-07
  • Large Shareholder at Nextcure Inc. (NXTC), 2019-05-15
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-20
  • Large Shareholder at Iterum Therapeutics Plc (ITRM), 2018-05-31
  • Director at Ocera Therapeutics Inc. (OCRX), 2017-02-10
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2016-10-24
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2015-10-13
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder at Hyperion Therapeutics Inc (HPTX), 2015-05-08
  • Large Shareholder at Spark Therapeutics Inc. (ONCE), 2015-01-30
  • Large Shareholder at Histogenics Corp (HSGX), 2014-12-10
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2014-09-15
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-12
  • Large Shareholder at Versartis Inc. (VSAR), 2014-03-28
  • Large Shareholder at Kalobios Pharmaceuticals Inc (KBIO), 2013-02-07
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2012-07-25
  • Director at Trius Therapeutics Inc (TSRX), 2012-03-27
  • Large Shareholder at Anthera Pharmaceuticals Inc (ANTH), 2012-01-04
  • Director at Orexigen Therapeutics Inc. (OREX), 2011-06-06
  • Large Shareholder at Amarin Corp Plc (AMRN), 2011-03-31
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MIRN $7.00 857,142 Large Shareholder, Director 2,974,811 2015-10-06 Filing
OCRX $6.03 4,400 Director 13,976 2013-07-15 Filing
OCRX $6.03 63,957 Director 203,152 2013-07-15 Filing
OCRX $6.03 322,809 Director 1,025,364 2013-07-15 Filing
TSRX $5.00 830,000 Large Shareholder, Director 3,615,572 2010-08-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OCRX $2.53 11,969 Director 0 2016-07-29 Filing
OCRX $2.29 74 Director 9,540 2016-09-12 Filing
OCRX $2.29 1,066 Director 138,686 2016-09-12 Filing
OCRX $2.29 5,372 Director 699,996 2016-09-12 Filing
TSRX $5.64 2,600 Director 113,100 2012-01-19 Filing